Nuveen Asset Management, LLC Vor Biopharma Inc. Transaction History

Nuveen Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.09 - $5.33 $220,947 - $381,116	71,504 New	71,504 $220,000
Q2 2022 Aug 15, 2022	SELL	$3.89 - $6.44 $215,101 - $356,106	-55,296 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.04 - $12.23 $6,329 - $12,817	1,048 Added 1.93%	55,296 $422,000
Q4 2021 Feb 14, 2022	SELL	$11.32 - $18.02 $48,393 - $77,035	-4,275 Reduced 7.3%	54,248 $666,000
Q3 2021 Nov 12, 2021	BUY	$12.24 - $20.38 $126,329 - $210,341	10,321 Added 21.41%	58,523 $899,000
Q2 2021 Aug 16, 2021	BUY	$18.65 - $38.78 $124,488 - $258,856	6,675 Added 16.07%	48,202 $899,000
Q1 2021 May 17, 2021	BUY	$30.96 - $54.08 $1.29 Million - $2.25 Million	41,527 New	41,527 $1.79 Million

41.1M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $53.3M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.